Spots Global Cancer Trial Database for Novel Thermal Imaging Technique for Breast Screening
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Novel Thermal Imaging Technique for Breast Screening
Official Title: A Phase II Study to Evaluate Accuracy of ThermalytixTM in Detecting Breast Cancer
Study ID: NCT05650086
Conditions
Interventions
Study Description
Brief Summary: This trial is to study a new breast imaging tool called Thermalytix™. ThermalytixTM is a new radiation-free, automated breast cancer screening technique that uses Artificial Intelligence (AI) over thermal images. Thermal images are heat signatures in our body. This new technique will capture heat signatures in the breast and analyze those images with AI software. This study will evaluate the performance of ThermalytixTM breast imaging against standard imaging modalities, such as mammography and ultrasound.
Detailed Description:
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
University of Arizona Cancer Center, Tucson, Arizona, United States
Contact Details
Name: Pavani Chalasani, MD
Affiliation: University of Arizona
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
